TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03464643 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT01095835 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04388670 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00563121 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00563121 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01501253 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03954236 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study NCT04416178 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03098901 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01669460 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02458664 — Predictive Biomarker (PRD): HSPH1 mRNA
Genes: HSPH1; HSP105; HSP110; KIAA0201
Study NCT02482922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01252953 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01180361 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study NCT01180361 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT03781102 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05275270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03489278 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01341652 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT01341652 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05281120 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05281120 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01949324 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT03882762 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00287131 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00869193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02323256 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT03320707 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01791686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04286074 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03243786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03243786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04183192 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06502301 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00553241 — Predictive Biomarker (PRD): ABCD2 mRNA
Genes: ABCD2; ALD1; ALDL1; ALDR; ALDRP
Study NCT03622762 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT03622762 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02453464 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04057287 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00880139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00880139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00880139 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04670107 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT05228639 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00496860 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00796328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01369368 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00915070 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04531124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01594658 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study NCT01813422 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02059213 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT03307343 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03307343 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04081701 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT02242825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03221114 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01116336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01116336 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00156767 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02802852 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02802852 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02802852 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT04456972 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT04456972 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04456972 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01515319 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00527085 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02773251 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03090880 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03717805 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT00062114 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01167829 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT04018404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02736123 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02736123 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03600883 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03161808 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02649335 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01423825 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT01423825 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03814564 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT03814564 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01507350 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01507350 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT04340063 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03110679 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01438229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02258074 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02258074 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04265547 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01151046 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00747305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00849121 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01440179 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01824940 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT00625560 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04217577 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04729491 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT04729491 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04729491 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT01448096 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04398147 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05271890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00170911 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03795779 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02622867 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03873805 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT03367000 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01543854 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03562078 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03562078 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study NCT03562078 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT03562078 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01358474 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT03886129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00878930 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01728181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02191059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02191059 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01923545 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00754455 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00250263 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03811418 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05504174 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05504174 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05504174 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04535882 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study NCT02432885 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03373968 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02243982 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02120677 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT00937963 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00937963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00937963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00937963 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04185272 — Predictive Biomarker (PRD): BTNL3 mRNA
Genes: BTNL3; BTNLR; COLF4100; UNQ744/PRO1472
Study NCT04185272 — Predictive Biomarker (PRD): BTNL9 mRNA
Genes: BTNL9; UNQ1900/PRO4346
Study NCT01397136 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01397136 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT03945773 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03945773 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04484012 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04225715 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02885038 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT03495063 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01428843 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02254772 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02254772 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT00966160 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01158118 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00773149 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00773149 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT00067600 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02492425 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03896594 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT03585556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02491099 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02491099 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04411576 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02157051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02157051 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03492138 — Safety Biomarker (SAF): DRD2
Study NCT04786496 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04373863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01975116 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00342654 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01521143 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02138565 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT02138565 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02956096 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02956096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01748773 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00473954 — Safety Biomarker (SAF): Interleukin 12
Study NCT01877603 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT01877603 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT01487057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01487057 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00760331 — Predictive Biomarker (PRD): HNF1B mRNA
Genes: HNF1B; TCF2
Study NCT01978925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03017807 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03017807 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02625701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05609617 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02589301 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03766594 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02669719 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02669719 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02767804 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00581737 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study NCT00581737 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01876667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01906372 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02066038 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02066038 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01447511 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00434824 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03846869 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03846869 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00001408 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01732224 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02977403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03036228 — Predictive Biomarker (PRD): NUDT1 mRNA
Genes: NUDT1; MTH1
Study NCT02659943 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04170452 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02764853 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02987010 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01486667 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06693037 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02449044 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02121028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05072496 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03236597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01970566 — Predictive Biomarker (PRD): NR3C2 mRNA
Genes: NR3C2; MCR; MLR
Study NCT00135850 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00135850 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02490072 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00975494 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00975494 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT01301794 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04896905 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01410227 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00776763 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00776763 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01983501 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01036087 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02960295 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04613167 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03603990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03603990 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03018925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02584608 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04692558 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03822754 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00095537 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00095537 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02396459 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study NCT00809432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00860886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04299087 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT00767260 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02916862 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT02916862 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02916862 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02551640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02947945 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01679327 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00081653 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04251078 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT04251078 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT04571125 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study NCT04571125 — Predictive Biomarker (PRD): SLC6A2 mRNA
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study NCT04571125 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT02563379 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03705117 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01066858 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01902719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01186835 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01001455 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00402103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01889407 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00260897 — Predictive Biomarker (PRD): COL2A1 mRNA
Genes: COL2A1
Study NCT00663234 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01515605 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study NCT01515605 — Predictive Biomarker (PRD): GATA4 mRNA
Genes: GATA4
Study NCT01515605 — Predictive Biomarker (PRD): GAPDH mRNA
Genes: GAPDH; GAPD; CDABP0047; OK/SW-cl.12
Study NCT01515605 — Predictive Biomarker (PRD): TRPC3 mRNA
Genes: TRPC3; TRP3
Study NCT01515605 — Predictive Biomarker (PRD): TRPC6 mRNA
Genes: TRPC6; TRP6